{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:55:06Z","timestamp":1783166106451,"version":"3.54.6"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","painmanagementnursing.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pain Management Nursing"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.pmn.2021.11.010","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T17:52:23Z","timestamp":1640713943000},"page":"532-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Self-Reported Severity, Characteristics, and Functional Limitations of Chemotherapy-Induced Peripheral Neuropathy"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-5068","authenticated-orcid":false,"given":"Robert","family":"Knoerl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-7336","authenticated-orcid":false,"given":"Emanuele","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elahe","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"McCleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ligibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlen","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pmn.2021.11.010_bib0001","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00520-019-05006-6","article-title":"Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study","volume":"28","author":"Ajewole","year":"2020","journal-title":"Supportive Care in Cancer"},{"issue":"5","key":"10.1016\/j.pmn.2021.11.010_bib0002","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.NNR.0000289503.22414.79","article-title":"Background noise: The experience of chemotherapy-induced peripheral neuropathy","volume":"56","author":"Bakitas","year":"2007","journal-title":"Nursing Research"},{"issue":"9","key":"10.1016\/j.pmn.2021.11.010_bib0003","doi-asserted-by":"crossref","first-page":"dju244","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"Journal of the National Cancer Institute"},{"issue":"2","key":"10.1016\/j.pmn.2021.11.010_bib0004","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ygyno.2018.12.002","article-title":"A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer","volume":"152","author":"Bulls","year":"2019","journal-title":"Gynecologic Oncology"},{"issue":"S2","key":"10.1016\/j.pmn.2021.11.010_bib0005","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1111\/jns.12337","article-title":"Chemotherapy-induced peripheral neurotoxicity: A multifaceted, still unsolved issue","volume":"24","author":"Cavaletti","year":"2019","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1016\/j.pmn.2021.11.010_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejon.2018.09.003","article-title":"Living with chemotherapy-induced peripheral neuropathy: Uncovering the symptom experience and self-management of neuropathic symptoms among cancer survivors","volume":"36","author":"Chan","year":"2018","journal-title":"European Journal of Oncology Nursing"},{"issue":"6","key":"10.1016\/j.pmn.2021.11.010_bib0007","first-page":"485","article-title":"Adolescent and young adult oncology\u2014past, present, and future","volume":"69","author":"Close","year":"2019","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"8","key":"10.1016\/j.pmn.2021.11.010_bib0008","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.pmn.2021.11.010_bib0009","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fnins.2017.00481","article-title":"A mechanistic understanding of axon degeneration in chemotherapy-induced peripheral neuropathy","volume":"11","author":"Fukuda","year":"2017","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"10.1016\/j.pmn.2021.11.010_bib0010","doi-asserted-by":"crossref","first-page":"djw206","DOI":"10.1093\/jnci\/djw206","article-title":"BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: The Pathways Study","volume":"109","author":"Greenlee","year":"2017","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1016\/j.pmn.2021.11.010_bib0011","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11136-013-0470-1","article-title":"Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"23","author":"Hay","year":"2014","journal-title":"Quality of Life Research"},{"issue":"25","key":"10.1016\/j.pmn.2021.11.010_bib0012","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1200\/JCO.2015.66.2346","article-title":"Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants 65 years or older in Southwest Oncology Group clinical trials","volume":"34","author":"Hershman","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/j.pmn.2021.11.010_bib0013","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NAN.0000000000000368","article-title":"Chemotherapy-induced peripheral neuropathy: nursing implications","volume":"43","author":"Kanzawa-Lee","year":"2020","journal-title":"Journal of Infusion Nursing"},{"issue":"4","key":"10.1016\/j.pmn.2021.11.010_bib0014","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.NAJ.0000742060.56042.e7","article-title":"CE: Chemotherapy-induced peripheral neuropathy","volume":"121","author":"Knoerl","year":"2021","journal-title":"American Journal of Nursing"},{"issue":"5","key":"10.1016\/j.pmn.2021.11.010_bib0015","doi-asserted-by":"crossref","first-page":"E134","DOI":"10.1188\/18.CJON.E134-E140","article-title":"Chemotherapy-induced peripheral neuropathy: Use of an electronic care planning system to improve adherence to recommended assessment and management practices","volume":"22","author":"Knoerl","year":"2018","journal-title":"Clinical Journal of Oncology Nursing"},{"issue":"1","key":"10.1016\/j.pmn.2021.11.010_bib0016","first-page":"236","article-title":"Exploring the impact of a decision support algorithm to improve clinicians\u2019 chemotherapy-induced peripheral neuropathy assessment and management practices: A two-phase, longitudinal study","volume":"21","author":"Knoerl","year":"2021","journal-title":"BioMed Central Cancer"},{"issue":"9","key":"10.1016\/j.pmn.2021.11.010_bib0017","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.pec.2019.04.012","article-title":"Characterizing patient-clinician chemotherapy-induced peripheral neuropathy assessment and management communication approaches","volume":"102","author":"Knoerl","year":"2019","journal-title":"Patient Education and Counseling"},{"issue":"7","key":"10.1016\/j.pmn.2021.11.010_bib0018","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jamaneurol.2016.0383","article-title":"The association of chemotherapy-induced peripheral neuropathy symptoms and the risk of falling","volume":"73","author":"Kolb","year":"2016","journal-title":"JAMA Neurology"},{"issue":"28","key":"10.1016\/j.pmn.2021.11.010_bib0019","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1016\/j.pmn.2021.11.010_bib0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.6004\/jnccn.2019.7290","article-title":"Balance deficits and functional disability in cancer survivors exposed to neurotoxic cancer treatments","volume":"17","author":"McCrary","year":"2019","journal-title":"Journal of the National Comprehensive Cancer Network\u00a0: JNCCN"},{"issue":"2","key":"10.1016\/j.pmn.2021.11.010_bib0021","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpainsymman.2016.12.342","article-title":"Chemotherapy-induced neuropathy in cancer survivors","volume":"54","author":"Miaskowski","year":"2017","journal-title":"Journal of Pain and Symptom Management"},{"issue":"30","key":"10.1016\/j.pmn.2021.11.010_bib0022","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1200\/JCO.2014.58.8533","article-title":"Clinical course of oxaliplatin-induced neuropathy: Results from the randomized phase III trial N08CB (Alliance)","volume":"33","author":"Pachman","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1016\/j.pmn.2021.11.010_bib0023","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jpainsymman.2019.04.029","article-title":"Deleterious effects of higher body mass index on subjective and objective measures of chemotherapy-induced peripheral neuropathy in cancer survivors","volume":"58","author":"Petrovchich","year":"2019","journal-title":"Journal of Pain and Symptom Management"},{"issue":"9","key":"10.1016\/j.pmn.2021.11.010_bib0024","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1007\/s00520-019-05254-6","article-title":"Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: A qualitative study","volume":"28","author":"Salgado","year":"2020","journal-title":"Supportive Care in Cancer"},{"issue":"12","key":"10.1016\/j.pmn.2021.11.010_bib0025","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.pmn.2021.11.010_bib0026","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s00520-011-1365-8","article-title":"Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients","volume":"20","author":"Speck","year":"2012","journal-title":"Supportive Care in Cancer"},{"issue":"S2","key":"10.1016\/j.pmn.2021.11.010_bib0027","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1111\/jns.12335","article-title":"Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment","volume":"24","author":"Staff","year":"2019","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"S2","key":"10.1016\/j.pmn.2021.11.010_bib0028","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1111\/jns.12336","article-title":"Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment","volume":"24","author":"Tamburin","year":"2019","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"3","key":"10.1016\/j.pmn.2021.11.010_bib0029","doi-asserted-by":"crossref","first-page":"e13011","DOI":"10.1111\/ecc.13011","article-title":"Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer","volume":"28","author":"Tanay","year":"2019","journal-title":"European Journal of Cancer Care"},{"issue":"5","key":"10.1016\/j.pmn.2021.11.010_bib0030","doi-asserted-by":"crossref","first-page":"e12443","DOI":"10.1111\/ecc.12443","article-title":"The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: A qualitative thematic synthesis","volume":"26","author":"Tanay","year":"2017","journal-title":"European Journal of Cancer Care"},{"issue":"3","key":"10.1016\/j.pmn.2021.11.010_bib0031","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1188\/10.CJON.E22-E28","article-title":"Patient perceptions associated with chemotherapy-induced peripheral neuropathy","volume":"14","author":"Tofthagen","year":"2010","journal-title":"Clinical Journal of Oncology Nursing"},{"issue":"5","key":"10.1016\/j.pmn.2021.11.010_bib0032","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11912-020-00903-0","article-title":"The physical consequences of chemotherapy-induced peripheral neuropathy","volume":"22","author":"Tofthagen","year":"2020","journal-title":"Current Oncology Reports"},{"issue":"3","key":"10.1016\/j.pmn.2021.11.010_bib0033","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/j.pain.0000000000000404","article-title":"Chemotherapy-induced pain and neuropathy: A prospective study in patients treated with adjuvant oxaliplatin or docetaxel","volume":"157","author":"Ventzel","year":"2016","journal-title":"Pain"},{"issue":"23","key":"10.1016\/j.pmn.2021.11.010_bib0034","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1200\/JCO.2016.71.3552","article-title":"Falls, functioning, and disability among women with persistent symptoms of chemotherapy-induced peripheral neuropathy","volume":"35","author":"Winters-Stone","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1016\/j.pmn.2021.11.010_bib0035","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1007\/s00520-019-04695-3","article-title":"Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors","volume":"27","author":"Wong","year":"2019","journal-title":"Supportive Care in Cancer"}],"container-title":["Pain Management Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904221002472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904221002472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:46:24Z","timestamp":1761500784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1524904221002472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1524904221002472"],"URL":"https:\/\/doi.org\/10.1016\/j.pmn.2021.11.010","relation":{},"ISSN":["1524-9042"],"issn-type":[{"value":"1524-9042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-Reported Severity, Characteristics, and Functional Limitations of Chemotherapy-Induced Peripheral Neuropathy","name":"articletitle","label":"Article Title"},{"value":"Pain Management Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmn.2021.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}